Horowitz in vivo study: Dapsone + doxy + rifampin very effective for chronic Lyme

A groundbreaking in vivo clinical study conducted by Dr. Richard Horowitz has found that an eight-week course of the leprosy drug dapsone combined with doxycycline and rifampin is effective in improving symptoms in 98% of patients suffering from chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS).

https://www.lymedisease.org/horowitz-dapsone-chronic-lyme/

Study
https://www.mdpi.com/2079-6382/9/11/725

There's a recent thread here: https://www.healingwell.com/community/default.aspx?f=30&m=4223167#gsc.tab=0